Androgen receptor expression as a prognostic and predictive marker in triple-negative breast cancer patientsFootnote

Peer review under responsibility of Alexandria University Faculty of Medicine.

Footnote

Available online 30 October 2015

References

• S.LoiblB.M.MullerG.von MinckwitzAndrogen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant chemotherapyBreast Cancer Res Treat1302011477487
   PubMed Web of Science ®Google Scholar
• S.ParkJ.S.KooM.S.KimAndrogen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancersAnn Oncol22201117551762
   PubMed Web of Science ®Google Scholar
• R.HuS.DawoodM.D.HolmesAndrogen receptor expression and breast cancer survival in postmenopausal womenClin Cancer Res17201118671874
   PubMed Web of Science ®Google Scholar
• J.HeR.PengZ.YuanPrognostic value of androgen receptor expression in operable triple-negative breast cancer: a retrospective analysis based on a tissue microarrayMed Oncol292012406410
   Web of Science ®Google Scholar
• Jennifer Richer. Androgen receptors found to be a potential target in Breast cancer. AACR news: studies show increasing evidence that androgen drives breast cancer. AACR Annual Meeting 2013. University of Colorado Denver.
   Google Scholar
• R.M.TamimiH.J.BaerJ.MarottiM.GalanL.GalaburdaY.FuComparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancerBreast Cancer Res102008R67
   PubMed Web of Science ®Google Scholar
• S.BudveD.J.DabbsS.J.SchnittBasal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pahologists and oncologistsMod Pathol2422011157167
   Web of Science ®Google Scholar
• E.A.RakhaM.E.El-sayedA.R.GreenPrognostic makers in triple-negative breast cancerCancer109120072532
   PubMed Web of Science ®Google Scholar
• Diazlkv.l.CrysW.F.SymmansTriple negative breast carcinoma and the basal phenotype: from expression profiling to clinical practiceAdr Anat Pathol1462007419430
   Web of Science ®Google Scholar
• AlbergariaAndreRicardoSaraMilaneziFernandaNottingham prognostic index in triple-negative breast cancer: a reliable prognostic tool?BMC Cancer112011299
   Web of Science ®Google Scholar
• R.DentM.TrudeauK1PritchardTriple-negative breast cancer: clinical features and patterns of recurrenceClin Cancer Res13IS200744294434
   Google Scholar
• X.R.YangM.E.ShermanD.L.RimmDifferences in risk factors for breast cancer molecular subtypes in a population based study-cancerEpidermiol Biomarkers, Prev1632007439443
   Web of Science ®Google Scholar
• K.R.BauerM.BrownR.D.CressDescriptive analysis of estrogen receptor ER-negative, progesterone receptor (PR)-negative and HER 2-negative invasive breast cancer, the so-called triple-negative phenotype: a population based study from the California cancer registryCancer1099200717211728
   PubMed Web of Science ®Google Scholar
• F.M.BlowsK.E.DriverM.K.SchmidtSubtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studiesPlots Med7s20101000279
   Google Scholar
• Amal AbdEl-HafezAbdEl-MageedMohamed Abd-El-atyShawkyDifferent prognostic factors correlate with BCL-2-expression among triple negative and non-triple negative BCAsian Pacific J Cancer Prev1420131041
   Google Scholar
• Doreen CBrady-WestDonovan AMcGrowderTriple negative breast cancer, therapeutic and prognostic implicationsAsian Pacific J Cancer. Prevention12201121392143
   PubMedGoogle Scholar
• V.Kuenen-BoumeesterH.vander kwastC.C.Cleas senThe clinical significant of androgen receptor in breast cancer and their relation to histological and cell biological parametersEur J Cancer1996 32A-1560-156s
   Web of Science ®Google Scholar
• G.VialeS.Z.N.RotmenP.MaisonneuveInfiltrating ductal carcinoma of the breast with TNBC phenotype: prognostic implications of EGFR immunoreactivityBreast Cancer Res Treat1162009317328
   PubMed Web of Science ®Google Scholar
• Rabab A.A.MohammedIan O.EllisAli M.MohmmodLymphatic and blood vessels in basal and triple-negative breast cancers: characteristics and prognostic significanceModern Pathol242011774785
   PubMed Web of Science ®Google Scholar
• E.A.RakhaS.E.ElsheikhM.A.AleskandaranyTriple-negative breast cancer: distinguishing between basal and non basal subtypesClin Cancer Res15200923022310
   PubMed Web of Science ®Google Scholar
• A.A.LuckA.J.EvansA.R.GreenThe influence of basal phenotype on the metastatic pattern of breast cancerClin Oncol (R Coll Radiol)2020084045
   PubMed Web of Science ®Google Scholar
• S.M.Rodriguez-PinillaD.SarrioE.HonradoPrognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomasClin Cancer Res12200615331539
   PubMed Web of Science ®Google Scholar
• L.G.FulfordJ.S.Reis FilhoK.RyderBasal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survivalBreast Cancer Res92007R4
   PubMed Web of Science ®Google Scholar
• ChoccalingamChidambharamRaoLakshmiRaoSrutiClinico-pathological characteristics of triple-negative and non-triple-negative. High grades breast carcinomas with and without basal markers (CKS 16 and EGFR) expression at a rural tertiary hospital in india breast cancerBasic Clin Res620122129
   Google Scholar
• K.BhumsukI.Seock-AhKyung-HunKi-67 can be used for further classification of TNBC into two subtypes with different response and prognosisBreast Cancer Res132011R2210.1186/bcr2834 <http://breast-cancer-research.com/content/13/2/R22>
   Google Scholar
• KristrinaJoensnuMarjutLeidenlusMiaKeroER, PR, HER-2, ki-67, cks in early and late relapsing: breast cancer-reduced CKS expression in metastasesBreast Cancer: Basic Clin Res720132334
   Google Scholar
• RoohiIsmail-KhanMarilyn M.BuiA review of triple-negative breast cancerCancer Control1732007173176
   Google Scholar
• Joseph P.GarayBedriKarakasAbde M.A.BukhdeirDavid P.GosgroveThe growth response to AR Signaling in ERX-negative human breast cancer cell is dependent on P21 and mediated by MAPK activationBreast142012R27 doi: 10.11861bcr3112
   Web of Science ®Google Scholar
• Careyl E.DeesL.SqwyerThe triple-negative paradox: primary tumor chemosensitivity of breast cancer subtypesClin Cancer Res13200723292334
   Web of Science ®Google Scholar
• C.LiedtkeC.MazouniK.HessResponse to neoadjuvant therapy and long-term Survival in patients with TNBCJ Clin Oncol26200812751281
   PubMed Web of Science ®Google Scholar
• L.J.MC GhanA.E.MC culloughC.A.ProtheroeAndrogen receptors positive TNBC: a unique breast cancer subtypeAnn Surg Oncol2122014361367 doi: 10.12451510434-013-3260-7-Epub2013Sep18
   Web of Science ®Google Scholar
• S.SparkJ.S.KooM.S.KimAndrogen receptors expression is significantly associated with better outcomes in ER – positive breast cancerAnn Oncol228201017551762
   Web of Science ®Google Scholar
• A.K.AgrawalM.JelenGrzebieniakzAR as a prognostic and predictive factor in BCFolia Histochem Cytobiol462008269276
   Web of Science ®Google Scholar
• V.OgawaE.HaiK.MatsumotoAR expression in breast cancer: relationship with clinicopathological factors and biomarkersInt J Clin Oncol132008431435
   Web of Science ®Google Scholar
• R.E.MoeBoAndersonAndrogen and androgen receptors a clinical neglected sector in breast cancer biologyJ Sur Oncol952007437439
   Web of Science ®Google Scholar
• Z.NahlehAndrogen receptor as a target for the treatment of hormone receptor-negative breast cancer: an unchartered territoryFuture Oncol420081521
   PubMed Web of Science ®Google Scholar
• K.HanleyJ.WanP.Bournelack of expression of AR may play a critical role in transformation from in situ to invasive basal subtype of high grade ductal Cacinoma of the breastHum Pathol392008386392
   Web of Science ®Google Scholar
• C.RivaE.DalneseG.CapraraImmuno histochemical study of androgen receptors in breast carcinoma. Evidence of their frequent expression in lobular carcinomasVirchows Arch4472005 965-700
   Google Scholar
• L.C.ChoY.H.HsuExpression of androgen, estrogen and progesterone receptors in mucinous carcinoma of the breast. Kaoh-suingJ Med Sci242008227232
   Google Scholar
• Aye AyeThikeLuke Yong-ZhengChongLoss of androgen receptor expression predicts early recurrence in triple-negative and basal-like breast cancerModern Pathol920131038 doi: 10.10381modpathol.2013.145
   Google Scholar
• Ashwani K.MishraUshaAgrawalShivaniNegiExpression of androgen receptor in breast cancer & its correlation with other receptor and growth factorsIndian J Med Res1352012843852
   Web of Science ®Google Scholar
• D.ShaheenabTNBC: epidemiology and management optionsDrugs70201022472258
   Web of Science ®Google Scholar
• Kaplan HG, Malngren JA, Al wood MK. Import of TNBC phenotype on breast cancer prognosis. Poster presented at: 29th annual san Antonio Breast cancer symposium. San Antonio, TX; 2006, December 14–17.
   Google Scholar
• M.C.CheangD.VoducC.BajdikBasal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotypeClin Cancer Res145200813681376
   PubMed Web of Science ®Google Scholar
• D.G.HicksS.M.ShortN.L.PrescottBreast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5/6, and overexpress HER2 or EGFRAm J Surg Pathol309200610971104
   PubMed Web of Science ®Google Scholar
• W.D.FoulkesI.E.SmithJ.S.Reis-FilhoTriple-negative breast cancerN Engl J Med36320201019381948
   PubMed Web of Science ®Google Scholar
• M.TischkowitzJ.S.BrunetL.R.BeginUse of immunohistochemical markers can refine prognosis in triple negative breast cancerBMC Cancer72007134
   PubMed Web of Science ®Google Scholar
• R.DentW.M.HannaM.TrudeauTime to disease recurrence in basal-type breast cancers: effects of tumor size and lymph node statusCancer11521200949174923
   Web of Science ®Google Scholar
• S.ParkJ.KooH.S.ParkExpression of androgen receptor in primary breast cancerAnn Oncol212009488492
   Web of Science ®Google Scholar
• GuozB.DaiJiantRegulation of androgen receptor activity by tyrosine phosphorylationCancer Cell102006309319
   Web of Science ®Google Scholar
• S.N.AgoffP.E.SwansonH.LindenAndrogen receptors expression in estrogen receptor-negative breast cancer. Immunohistochemical, clinical and prognostic associationsAm J Clin Pathol1207200325731
   Google Scholar
• S.Toth-fejelJ.cheekCalhounkEstrogen and androgen receptors as comediators of breast cancer cell prolifrationArch Surg1392004 50-S4
   Google Scholar
• A.A.ThikeL. Yong-ZhengChongP.Y.CheokLoss of AR expression predicts early recurrence in triple-negative and basal-like breast cancerMoodern Pathol2732014352360
   Web of Science ®Google Scholar
• ChelseaHardinRodneyPommierKristineCalhounA new hormonal therapy for estrogen receptor-negative breast cancerWorld J Surg31200710411046 doi: 10-10071S00268-007-0694-8
   Web of Science ®Google Scholar
• Mod pathology. Androgen R in breast cancer: Expression in ER +ve tumors and ER-negative tumors with apocrine differentiation USA. Leo Aniemeier; 2010.
   Google Scholar
• Traina A, Wolff AC, Girik Feigin D. AR inhibition for the treatment of AR+ve, ER-ve, PR-ve, metastatic breast cancer. 2009 Breast cancer symposium. (Asco home) Momorial Sloan-Kettering cancer center, New York, NY. Translational Breast cancer Research Con Sortium, Baltimore MD; 2009.
   Google Scholar
• A.GucalpM.T.SaraJ.StevenASCO, targeting the androgen receptor (AR) in women with AR/PR-metastatic breast cancer (MBC)J Clin Oncolsuppl; abstr 1006201230 <http://meetinglibrary.asco.org/content/94715-114>
   Google Scholar
• M.CheangAsco. Triple-negative breast cancer and treatment: what do we know?Clin Cancer Res142012 1368-1367
   Google Scholar
• NaderiAliHughes-DavisLukeA functionally significant cross-talk between AR and ERB2 pathways in estrogen receptor negative BCNeoplasia1062008542548
   Web of Science ®Google Scholar
• F.MoinfarM.OkcuO.TsybrovskyyAR frequently are expressed in breast carcinoma: potential relevance to new therapeutic strategiesCancer982008703711
   Google Scholar
• A.R.TanS.M.SwainTherapeutic strategies for TNBCCancer J142008343351
   Web of Science ®Google Scholar
• Payal DShahAycaGucalpTiffany A.TrainaThe role of the androgen receptor in triple-negative breast cancerWomen’s Health94201335136010.2217/whe.13.33
   Google Scholar